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report (MOHR) project
Alex H Krist1*, Beth A Glenn2, Russell E Glasgow3, Bijal A Balasubramanian4, David A Chambers5,
Maria E Fernandez6, Suzanne Heurtin-Roberts3, Rodger Kessler7, Marcia G Ory8, Siobhan M Phillips3,
Debra P Ritzwoller9, Dylan H Roby2, Hector P Rodriguez2, Roy T Sabo10, Sherri N Sheinfeld Gorin11,12,
Kurt C Stange13 and The MOHR Study GroupAbstract
Background: There is a pressing need for greater attention to patient-centered health behavior and psychosocial
issues in primary care, and for practical tools, study designs and results of clinical and policy relevance. Our goal is
to design a scientifically rigorous and valid pragmatic trial to test whether primary care practices can systematically
implement the collection of patient-reported information and provide patients needed advice, goal setting, and
counseling in response.
Methods: This manuscript reports on the iterative design of the My Own Health Report (MOHR) study, a cluster
randomized delayed intervention trial. Nine pairs of diverse primary care practices will be randomized to early or
delayed intervention four months later. The intervention consists of fielding the MOHR assessment – addresses 10
domains of health behaviors and psychosocial issues – and subsequent provision of needed counseling and
support for patients presenting for wellness or chronic care. As a pragmatic participatory trial, stakeholder groups
including practice partners and patients have been engaged throughout the study design to account for local
resources and characteristics. Participatory tasks include identifying MOHR assessment content, refining the study
design, providing input on outcomes measures, and designing the implementation workflow. Study outcomes
include the intervention reach (percent of patients offered and completing the MOHR assessment), effectiveness
(patients reporting being asked about topics, setting change goals, and receiving assistance in early versus delayed
intervention practices), contextual factors influencing outcomes, and intervention costs.
Discussion: The MOHR study shows how a participatory design can be used to promote the consistent collection
and use of patient-reported health behavior and psychosocial assessments in a broad range of primary care
settings. While pragmatic in nature, the study design will allow valid comparisons to answer the posed research
question, and findings will be broadly generalizable to a range of primary care settings. Per the pragmatic
explanatory continuum indicator summary (PRECIS) framework, the study design is substantially more pragmatic
than other published trials. The methods and findings should be of interest to researchers, practitioners, and policy
makers attempting to make healthcare more patient-centered and relevant.
Trial registration: Clinicaltrials.gov: NCT01825746
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There is significant interest in transforming health infor-
mation technology to be more patient-centered [1-3].
To further integrate these movements toward patient-
centeredness and information technology-supported
healthcare, one key element that has been missing is a
set of brief, practical patient-reported items that are rele-
vant to and actionable by patients and their healthcare
team [4,5]. In 2011, 93 national primary care, public
health, health behavior, and psychosocial experts as well
as patients engaged in a rigorous three-phase process to
identify evidence-based, patient-reported measures that
if routinely collected could be used to improve health
and monitor health status [6]. The process included
assembling all possible candidate measures, using a grid-
enabled measures wiki platform to identify key measures
for consideration [7], and a town hall meeting to finalize
the measures. From this process, 17 brief, feasible
screening questions evaluating 10 domains of health
behaviors and psychosocial problems were identified [8].
Before these patient-reported measures are fully inte-
grated into health risk assessments or routinely inte-
grated into electronic health records (EHRs) and patient
portals, research is needed to evaluate relevance, feasibil-
ity, and impact on care [9-11]. Randomized pragmatic
implementation studies are one way to efficiently and
rapidly make this evaluation [12]. Key to pragmatic stud-
ies is stakeholder involvement, of both clinicians and pa-
tients, and outcomes important to potential adoption
settings. Table 1 summarizes the key characteristics of
pragmatic trials compared to traditional efficacy trials in
terms of measures, costs, focus and other dimensions.
As shown, there are major differences in the formulation
of study questions, methods issues receiving the greatestTable 1 Distinguishing differences between pragmatic and tr
Pragmatic study
Stakeholder
involvement
Engaged in all study phases including study design, conduct
collecting data, interpreting results, disseminating findings
Research
Design
Includes internal and external validity, design fidelity and loc
real life settings and populations, contextual assessments
Outcomes Reach, effectiveness, adoption, implementation, comparative
sustainability
Measures Brief, valid, actionable with rapid clinical utility, feasible in rea
low-resource settings
Costs Assessments include intervention costs and replication costs
to outcomes
Data Source May include existing data (electronic health records, adminis
and brief patient reports.
Analyses Process and outcome analyses relevant to stakeholders and
perspectives
Availability of
findings
Rapid learning and implementationpriority, outcomes and analysis, and level of stakeholder
involvement. Despite the differences, if properly designed,
both study designs can yield scientifically valid answers to
posed research questions. The Consolidated Standards of
Reporting Trials (CONSORT) group has also developed a
reporting standard and a helpful summary figure, called
the Pragmatic Explanatory Continuum Indicator Sum-
mary (PRECIS), to report the extent to which an interven-
tion study is pragmatic versus explanatory on 10
dimensions [13,14].
The purposes of this manuscript are to describe the
background, engagement of stakeholders, characteristics
of participating primary care practices, study design in
relation to the pragmatic explanatory continuum, key
outcomes, and automated tool and feedback system de-
veloped for the My Health Outcomes Report (MOHR)
study.
Methods
Overall design
The MOHR study is a paired, cluster (practice level)
randomized, non-blinded, practical, implementation
study that uses a delayed intervention design with 9
pairs of primary care practices (18 total). The design
combines elements of pragmatic trials, implementation
science, systems science, and mixed methods ap-
proaches, and engages stakeholders as partners through-
out the study design, implementation, evaluation and
subsequent dissemination. One practice in each pair will
be randomized to early implementation, and the second
to delayed implementation four months later. Imple-
mentation will consist of each practice defining a patient
population and workflow and then fielding the system-
atic collection of the patient reported measures in dailyaditional clinical efficacy trials
Traditional clinical efficacy
ing the study, Limited engagement, often in response to investigator
ideas or study subjects
al adaptation, Focus on limiting threats to internal validity, typically
uses randomized controlled trial, participants and
settings typically homogenous
effectiveness, Efficacy, mechanism identification, component analysis
l world and Validated measures that minimize bias, focus on
internal consistency and theory rather than clinical
relevance
in relation Often not collected or reported
trative data) Data generation and collection part of clinical trial
from different Specified a priori and typically restricted to investigator
hypotheses
Delay between trial completion and analytic availability
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measures and costs that are relevant to potential
adopting and funding agencies [15-19]. Patient goal-
setting and clinical follow-up in the 10 health behavior
and psychosocial domains will be compared between
early and delayed intervention sites prior to implementa-
tion of the MOHR assessment in delayed intervention
sites, thus delayed intervention practices effectively serve
as control practices. Feasibility will be assessed by moni-
toring implementation in both early and delayed imple-
mentation sites (see Figure 1 for project overview and
timeline). The project is funded through a unique part-
nership of grant supplementation from the National
Cancer Institute (NCI), the Agency for Healthcare
Research and Quality (AHRQ), and the Office of
Behavioral Social Sciences Research (OBSSR).
Research teams and study settings
To carry out this pragmatic trial, partnerships were cre-
ated between local research teams at eight nationallyFigure 1 MOHR study overview and timeline. The study started in Janu
implementation practices is March 2013 and July 2013 for the delayed imp
implementation sites, DIS = delayed implementation sites).distributed academic institutions that manage a practice-
based research network (PBRN) or participate in the
Cancer Prevention and Control Research Network
(CPCRN) [20,21]. Given the network affiliations, each
research team has expertise in partnering with their
practice and patient stakeholders. Accordingly, research
teams are charged with helping their partner practices
implement the patient-reported assessment and carry
out the MOHR study protocol, while balancing the need
for adaptation to ensure implementation is relevant to
local culture and practice flow (see ‘Balancing fidelity
and adaption,’ below) [22]. To coordinate activities
across the project, a MOHR planning committee com-
posed of representatives from all local research teams
and practices will have joint bimonthly meetings for
planning (pre-implementation) and to share successes
and challenges (post-implementation). The organization
and coordination of activities is depicted in Figure 2.
Research teams identified one or two pairs of primary
care practices within their network that were similarary 2013. The approximate implementation date for the early
lementation practices. (IRB = institutional review board, EIS = early
Funders
Project coordination
Local Research Teams
Study practices Site
# 17
Site
# 13
Site
# 15
Site
# 2
Site
# 9
Site
# 11
Site
# 5
Site
# 7
Site
# 1
Site
# 3
Site
# 4
Site
# 6
Site
# 8
Site
# 10
Site
# 12
Site
# 14
Site
# 16
Site
# 18
ACORN Texas 
A&M
OCHIN
Carilion UV
UNC
UCLA UTH
Coordination Center
Virginia Commonwealth 
University, Dept. Family 
Medicine
Web tool 
and practice 
training
Patient 
experience 
survey
Clinical 
context
Cost 
collection 
and analysis
Publication, 
presentation, 
and relations
MOHR Planning 
Committee
Representatives of local 
research teams and sites
Agency for 
Healthcare Research 
and Quality
Office of Behavioral 
and Social Sciences 
Research
National Cancer 
Institute
Figure 2 MOHR study organization and coordination. The four general partners include funders, project coordination, local research teams,
and study practices. The funders provide project coordinators general input into the study implementation and design. Overall project
coordination includes the five working groups, MOHR planning committee, and the coordination center. The local research teams directly
coordinate with the nine practice pairs to carry out and support the MOHR implementation and evaluation. (ACORN = Virginia Ambulatory Care
Outcomes Research Network, UV = University of Vermont, UNC = University of North Carolina, UCLA = University of California, Los Angeles, and
UTH = University of Texas Houston).
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ily practice or internal medicine), practice ownership,
geographic region, EHR infrastructure, and patient
population served. Practice pairs were purposefully se-
lected to represent the diversity of primary care settings
and populations to ensure greater generalizability of re-
sults. Practices were randomly allocated to the early or
delayed condition by coin toss. To conceal allocation,
the researchers randomizing practices (i.e., project co-
ordination members) were blinded to practice name;
practices were labeled by number in paired blocks (by
local research teams), and identity was revealed to all
participants one week later during a joint call.
Table 2 presents the characteristics of the 18 partici-
pating practices. The PBRN practices tend to have
higher proportions of insured patients and fewer ethnic
minorities compared to the FQHCs. Most practices are
small to medium in size, with one to six providers and
seeing 1,500 to 10,000 unique adult patients annually.
All practices, except two, have EHRs. While nearly halfof practices have initiated or received patient-centered
medical home designations, most report limited experi-
ence with behavioral health and varying levels of experi-
ence with quality improvement.
Work groups
To facilitate rapid, collaborative decision making on im-
portant issues relevant to the MOHR study design and
implementation, work groups were formed consisting of
research team members, clinicians, funding agency
representatives, and content experts. Each work group is
responsible for effectively solving issues related to their
specific MOHR study area and bringing proposals to the
larger collaborative for approval. Work groups include:
Web Tool and Practice Training Work Group – to de-
sign and test an electronic version of the comprehen-
sive behavioral and psychosocial risk assessment,
www.MyOwnHealthReport.org, for practices to use
and to create training sessions to prepare practices to
address topics identified by the MOHR assessment;
Table 2 Participating practice characteristics
Site State Setting Patients seen per year Provider FTEs Rooming staff FTE Patient ethnicity and race Insurance type
Latino Black Medicare Medicaid None
1 VA S 5,000 2 4 15% 10% 5% 0% 30%
2 VA S 1,500 1 2 20% 10% 1% 0% 9%
3 VA R 2,500 1.6 7 1% 49% 12% 1% 49%
4 VA S 5,200 4 11 2% 18% 15% 2% 18%
5 VA U 3,700 5.9 17.3 2% 39% 24% 2% 39%
6 VA U 3,400 5.3 16.9 1% 17% 26% 1% 17%
7 CA R 3,500 5.5 15 3% 1% 13% 3% 1%
8 CA R 5,400 7 25.5 13% 2% 12% 13% 2%
9 VT R 9,500 5 13.5 1% 5% 13% 1% 5%
10 VT R 10,000 5 14 1% 2% 15% 1% 2%
11 NC R 1,100 4.5 12 2% 60% 49% 2% 60%
12 NC R 7,500 3.5 10 40% 60% 10% 10% 70%
13 CA U 2,040 1 7 75% 25% 5% 45% 50%
14 CA U 2,180 2 6 75% 25% 5% 45% 50%
15 TX R 4,800 2 6 48% 23% 2% 48% 23%
16 TX R 3,800 2 6 23% 32% 2% 23% 32%
17 TX U 2,800 3 19 82% 6% 1% 82% 6%
18 TX U 2,800 3.6 12 80% 5% 1% 80% 5%
Notes:
Practices 1-10 belong to a practice based research network and practices 11-18 belong to the Cancer Prevention and Control Research Network.
All practices except Site 2 and 3 have an electronic health record.
All practices have experience with prior research or quality improvement projects.
FTE Full Time Equivalent.
S Suburban, R Rural, U Urban.
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Patient Experience Survey (see ‘Outcomes assessment’ ,
below) for assessing main patient-level outcomes;
Clinical Context Work Group – to identify and evalu-
ate how key practice, patient, and environmental con-
textual issues impact implementation; Cost Collection
and Analyses Work Group – to measure the practice
costs of implementing the MOHR assessment; and Publi-
cation, Presentation, and Relations Work Group – to
promote opportunities for participants to present and
publish findings, coordinate with relevant stakeholder
entities, and create a repository of materials, tools, and
disseminated findings.
Intervention
The intervention being studied is the systematic imple-
mentation and fielding of the MOHR health behavior
and psychosocial assessment, including the delivery of
brief customized patient and provider feedback reports.
Each local research team worked with their practice pair
champions and key stakeholders to determine the most
effective workflow for administering the MOHR assess-
ment, including: (a) which patients would be invited to
complete the assessment, (b) when the assessmentwould be completed (e.g., two weeks before a visit, im-
mediately before a visit), (c) where the assessment would
be completed (home or practice), (d) whether the assess-
ment would be electronic or paper based, and (e) how
clinicians would receive MOHR feedback summaries
within the context of office visits. This is consistent with
the original NIH consensus panel’s goal of identifying
and standardizing patient reported elements to be incor-
porated into EHRs while minimizing staff burden and
enhancing consistency of implementation. As a result,
the practice pairs were encouraged to field the electronic
version of the MOHR assessment if possible [8].
Because it was not feasible to fully integrate the
MOHR assessment into each of the diverse practice’s
EHR and patient portal, a stand alone, publically avail-
able website (www.MyOwnHealthReport.org) was cre-
ated. The MOHR website is partially integrated with the
study practices’ existing EHRs and administers the 17
health behavior and psychosocial screening questions
(including basic demographics) as defined by the NIH
consensus panel [6,8]. In response to positive depression,
anxiety, alcohol, and drug screening questions, the
website seamlessly prompts the patient to complete
more in-depth assessments, including the Patient Health
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Disorder (GAD) questionnaire [24,25], the Alcohol Use
Disorders Identification Test (AUDIT-C) [26], and the
Drug Abuse Screening Test (DAST-10) [27], respect-
ively. The MOHR website scores the patient’s responses
and characterizes them as being of ‘no concern’ , ‘some
concern’, or ‘high concern’ based on norms and national
guidelines. For measures with ‘some’ or ‘high concern’ , pa-
tients are asked to select which topics they are ready to
change and/or discuss with their doctor and select the one
topic they feel is most important to address [28-31].
After completing this process, patients are taken to a
feedback page to review, download and print (see
Figure 3). Health domains in which they are doing well
are highlighted and reinforced, initial recommendations
for changes and improvements are given for domains
where improvements are needed, and space is provided
to list any questions, decide on and create up to three
SMART goals (specific, measurable, achievable, realistic
and timely), and outline follow-up steps to help achieve
their goals [32,33]. When patients have finished
reviewing their feedback page and leave the website, a
clinician summary is also sent to the patient’s primary
care team.
Practice implementation preparation
Practices are being prepared to implement the MOHR
assessment through a series of calls and meetings with
the site champions, an educational webinar with an
interactive ‘call in’ and case scenarios, support materials,
and on-site consultation for follow-up. The webinars
have been designed using the principles of adult learn-
ing, including multiple modalities, reinforcement, mod-
eling and observation. The follow-up consultations have
been modeled on academic detailing that entails a brief
face-to-face intervention with the clinician, repeated at
periodic intervals [34-36]. Academic detailing has been
found effective in improving other aspects of clinical
care such as cancer screening and chronic disease ma-
nagement [37-43].
The webinars present the evidence supporting the
MOHR assessment, strategies for successful practice im-
plementation of risk assessments, and approaches to
counseling and supporting patients as they address iden-
tified problem behaviors and psychosocial issues. The
webinars, as academic detailing, distill the evidence into
brief, practical messages that are relevant to and action-
able for primary care clinicians. The webinar and local
research team consultations seek to change staff atti-
tudes and beliefs toward implementing the MOHR as-
sessment though persuasive communications, including
case examples, tailored feedback and reinforcement [44].
Feedback and reinforcement will include weekly practice
reports on the number of patients completing theMOHR assessment and bimonthly meetings between
practice champions and local research teams to share
cross project implementation experiences and review the
local implementation process.Data sources
Outcomes will be collected from three sources: practice
appointment records, the Patient Experience Survey, and
patient responses to the MOHR assessment. Appoint-
ment records will be used for calculating Reach (see
‘Primary outcomes’, below). Reach measures are col-
lected when practices enter the intervention phase,
months two to six for early intervention practices and
months seven to nine for delayed intervention practices.
Appointment records are queried by the practices (elec-
tronically or manually) for patients who meet inclusion
criteria, are documented, de-identified, and transferred
to a central data coordination center every two weeks.
The Patient Experiences Survey will be used to compare
the early versus delayed intervention practices on patient
reports of patient-provider discussions, recommenda-
tions for referrals, and collaborative goal-setting across
the 10 health domains. The patient responses to the
MOHR assessment will be used for calculating patient
health behavior and psychosocial changes over time.
This will be assessed by repeated administration of the
MOHR assessment for the cohort of patients who
complete the assessment on the website and provide
email addresses (see ‘Outcomes assessment’ , below).
The content of the Patient Experience Survey and fiel-
ding protocol were developed by the working group,
building on earlier pilot phase experiences and practice
input, with the intention of balancing scientific rigor and
patient needs, practice capabilities, and resource avail-
ability across the diverse settings. The survey questions
were standardized. The 5As framework (Assess, Advise,
Agree, Assist and Arrange) served as a guide for devel-
oping questions for each health domain [45]. Questions
from the Consumer Assessment of Healthcare Providers
and Systems (CAHPS) assessing patient trust in their
healthcare team and perceived provider communication
style were also included [46]. Practices will mail the Pa-
tient Experience Survey to patients that the early and de-
layed intervention practices defined as eligible to receive
the MOHR assessment two weeks after the patient’s of-
fice visit. To enhance survey response rates, surveys will
be mailed using a modified Dillman technique in the
practice’s envelope with a cover letter from the patient’s
provider [47,48]. Study information will be included with
the survey, and completion of the survey will be deemed
as consent for participating in the survey – our Institu-
tional Review Board approved a waiver of written
consent.
Figure 3 Patient summary and feedback from www.MyOwnHealthReport.org. The first page demonstrates the patient’s health behavior and
psychosocial scores, level of concern, and whether the patient reported readiness to change and interest in talking with their doctor. The second
page includes patient workspace for notes, creation of SMART health goals, and a follow-up plan.
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The primary outcomes for this study are implementation
measures [15]. The measures include the practices’ im-
plementation Reach and Effectiveness [49]. Reach mea-
sures include the percent and characteristics of patients
that: are defined as eligible to be invited to complete the
MOHR assessment; are invited to complete the MOHR
assessment; and complete the MOHR assessment. The
primary Effectiveness measures are a comparison of
early versus delayed intervention practice patient report
on whether they: were asked about the health behavior
and psychosocial domains; set a goal or action plan with
their clinician; and arranged any follow-up contact re-
garding their plan. As early intervention practices will
have implemented the MOHR assessment and delayed
intervention practices will not yet have implemented the
MOHR assessment, they will respectively serve as inter-
vention and control conditions. The impact on health
behaviors and psychosocial problems will be assessed by
repeated administration of the MOHR assessment for
the subset of patients providing an email address. Patient
responses will be compared at baseline and four months
after baseline. Multivariate regressions will assess for
influences of practice implementation characteristics
(e.g., electronic versus paper) and patient demographics
on each outcome. The overall CONSORT diagramPractices rando
delayed interv
Early intervention practices offer  
MOHR to patients (n = 300+)
All patients mailed the 
Patient Experience 
Survey (n = 300+)
Analysis of survey 
responses 
(Effectiveness)
Number and  
characteristics of  
patients completing  
MOHR (Reach)
Practices pro
contextual a
expenditure d
(n = 9)
Nu
chara
patient
MOH
Months
3 to -7
Months
7-10
Figure 4 MOHR study CONSORT flow diagram.depicting study participation and data capture are
depicted in Figure 4.Power and sample size analysis
To determine power, we focused on the patient report as
to whether any practice personnel worked with her/him
to set specific goals for change for the 10 behavior and
mental health topics. For the base power analysis, we as-
sumed 9 matched pairs of sites, 300 patients mailed the
Patient Experience Survey from each site, and a 50% re-
sponse rate (2,700 total respondents). Imputation ana-
lyses will be conducted to evaluate the impact of missing
data, but here we assume the loss of up to 50% of the
sample for power calculation purposes. For the first
power analysis, we focus on the binary event that at least
one goal was established (as opposed to none). Assum-
ing a delayed intervention response rate of 0.3, there is
90% power to detect a 17.5% improvement in the early
versus delayed intervention group, and 80% power to de-
tect a 15% improvement.
For the second power analyses, we focus on the con-
tinuous outcome of the number of goals established
using a hierarchical analysis of covariance. We adjust for
any baseline differences in variables related to the out-
come as well as clustering effects of patients withinmized to early or  
ention (n = 18)
Delayed intervention practices identify  
control cohort of patients (n = 300)
Control patients mailed 
the Patient Experience 
Survey (n = 300)
vide 
nd 
ata 
Analysis of survey 
responses 
(Effectiveness)
mber and 
cteristics of 
s completing 
R (Reach)
Delayed intervention 
practices offer  
MOHR to patients 
(n = 300+)
Delayed intervention practices provide 
contextual and expenditure data (n = 9)
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(ICC) of 0.03, there is 90% power to detect a between
conditions effect size of 0.47 with 9 sites per treatment
and a 50% patient response rate, and 80% power to
detect an effect size of 0.40. Assuming a larger ICC of
0.05, we have 80% power to detect an effect size of 0.51
and 90% power to detect a difference of 0.60, given
the assumptions above. All power analyses were
performed using the ‘Optimal Design Software’ pack-
age (version 3.0).
Contextual assessments
An important aspect of a pragmatic trial is that it is
implemented in ‘real-world’ contexts, making it essential
that these contexts be described to understand differen-
tial outcomes [50]. Accordingly, local research teams will
collect data on multiple levels of contextual factors
[51-53]. Levels will include national/state/local, commu-
nity, healthcare system, practice and patient [54]. Con-
textual factors will include practice culture and staffing,
patient panel characteristics, community characteristics
and resources, and organizational features [55]. Local re-
search teams will collect relevant data through struc-
tured interviews with clinicians and through field
observations of clinical, social and organizational pro-
cesses and interactions as practices field the MOHR
assessment at the baseline, middle and end of the inter-
vention to assess changes in context. Quantifiable char-
acteristics will be incorporated from initial practice
descriptions made during recruitment. Teams will use a
standardized template to systematically elicit and record
contextual data.
Cost assessment
The MOHR cost assessment will evaluate both the im-
plementation costs and the replication costs using cost
assessment procedures that are minimally intrusive and
burdensome [19]. Using standardized a procedure, local
research teams will collect each practice’s cost estimate
following brief training. This person will use a combin-
ation of procedures, including observation of the inter-
vention and brief standardized structured questions of
key practice implementation staff. Cost data will be col-
lected at two time points – early in the implementation
and once a steady state has been reached. Calculations
will be made using established expenditure methods,
and replication costs will be categorized based upon
different practice and implementation characteristics
[56-59]. The cost assessments will be conducted from
the practice perspective and will include costs of recruit-
ment, promotion, training, supervision, implementation
and follow-up. Data collected during the trial will be
used to estimate the cost of a practice replicating the
MOHR assessment setting under different conditionsand assumptions. Research costs, downstream costs of
increased or reduced healthcare utilization, and costs
from the patient perspective will not be considered.
Balancing fidelity and adaption
To maintain internal validity, certain components of the
intervention were standardized. All participating prac-
tices will implement these components, and fidelity to
implementation will be assessed. However, to reflect the
pragmatic nature of the trial, practices were encouraged
to adapt aspects of the intervention to their workflow
and setting [22]. This is necessary because the MOHR
study purposively includes practices that vary widely
with respect to patients (mostly minority versus non-
minority), location (rural versus urban), and EHR and
patient portal use. Therefore, to ensure successful
implementations as well as high assessment and survey
response rates, each practice pair considered its patients’
needs. The elements that needed to be standardized
were decided by the overall project steering committee
and working groups, while decisions about local tailoring
were made by the practice pairs with support and direc-
tion from the local research team.
Standard study elements include the MOHR health
behavior and psychosocial assessment questions, provi-
sion of patient and provider feedback summaries based
on the MOHR assessment, goal-setting materials and
brief training to support clinicians with counseling, and
Patient Experience Survey questions. Practice pairs are
collaboratively deciding which patients to target for the
MOHR assessment, while attempting to include the lar-
gest percentage of adult patients that is feasible; timing
of the MOHR assessment (one to two weeks prior to a
visit at the patient’s home or immediately prior to a visit
at the practice); mode of the MOHR assessment (website
or paper), delivery of clinician summary (integrated into
EHR, faxed, printed); and mode of administering the Pa-
tient Experience Survey (postal, web-based, telephone or
a combination).
Trial status
The MOHR trial began January 2013 and is expected to
complete data collection in November 2013. The trial is
proceeding according to the timeline outlined in Figure 1.
Currently, the early implementation clinics are in the
early stages of fielding the MOHR assessment to their
patients. The delayed intervention clinics will begin im-
plementation between July and September 2013.
Discussion
This manuscript describes the need and plans for an im-
portant ongoing pragmatic study of the administration
and use of patient-reported items in primary care, illus-
trating key features of implementation design with both
Krist et al. Implementation Science 2013, 8:73 Page 10 of 13
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realities of research and practice. A central tenant
throughout the process has been ensuring the relevance
of the intervention, measures, and methodologies to
stakeholders [10,12].
Figure 5 summarizes the characteristics of the MOHR
study on the 10 CONSORT PRECIS dimensions.
Overall, the MOHR study is highly pragmatic, receiving
completely pragmatic scores on three dimensions (inter-
vention flexibility, control flexibility, and practitioner
expertise) and the next most pragmatic rating on the
seven remaining dimensions. These scores are substan-
tially more pragmatic than other published trials [60].
Implementation science involves controlled research,
in this case a cluster randomized delayed intervention
trial, but that is pragmatic and thus more directly rele-
vant to real-world settings [9,61,62]. By engaging all of
the stakeholders on the front-end about the importance
of healthcare process and outcome metrics for
documenting healthcare quality, the results should be
more directly usable by both primary care and potential
funding and reimbursement agencies. This is especially
so when including practical measures that can be em-
bedded into clinical systems [63], applying a feasible and
flexible intervention that provides direct feedback based
on these practical measures, and assessing outcomes of
importance to patient, provider, and policy maker stake-
holders, including costs.
This type of science is needed because ‘evidence alone
is not enough’ [64,65]. In addition to the best evidence,Flexibility of 
the comparison
intervention
Participant 
compliance
Follow-up
intensity
Practitioner
expertise
(comparison)
Outcomes
Figure 5 Depiction of the MOHR study PRECIS characteristics. The MO
flexibility, control flexibility, and practitioner expertise. The MOHR study des
seven dimensions.as in this case recommendations for primary care-based
health behavior and psychosocial counseling, other ele-
ments are needed [66,67]. As noted in the Evidence
Integration Triangle framework, other necessary compo-
nents for successful implementation are practical
measures of progress that can be tracked longitudinally
(in MOHR, these are the 17 items), and partnership en-
gagement processes, as illustrated above [64].
A major advantage of the MOHR trial for advancing
both scientific and practice frontiers is its diversity of
settings. Participating primary care settings include prac-
tices that already have adopted state-of-the art e-health
technologies for tracking patients’ care, enabling an
examination of the merger of patient-centered assess-
ment and intervention approaches and EHRs in high
resourced settings [68,69]. On the other end of the con-
tinuum, inclusion of a number of community health
centers, typically with less access to state-of-the art tech-
nologies, has generated problem-solving about the best
strategies for conducting assessment and interventions
in contexts where staff are challenged to see large
caseloads of more diverse, low income/low educated
populations with characteristically complex medical and
psychosocial needs, and lower levels of health literacy
and numeracy [70]. The mantra remains consistent: in-
volving relevant stakeholders is important for both the
initial adoption as well as the long-term sustainability of
evidence-based patient assessment and intervention.
This requires an understanding of the realities of the
practice flow, an appreciation for the context of patientPractitioner
expertise
(experimental)
Flexibility of the
experimental 
intervention
Eligibility
criteria
Primary
analysis
Practitioner
adherence
0
HR study design receives completely pragmatic scores for intervention
ign receives the next most pragmatic rating on the remaining
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back mechanisms that can be implemented with min-
imal resources.
From a traditional perspective, there are several limita-
tions or weaknesses to the MOHR design. Scientifically,
there are several questions the trial will be unable to ad-
dress. The MOHR assessment will not be linked at the
individual level to the follow-up Patient Experiences
Survey, and the design selected precludes the examin-
ation of the long-term behavioral or biological health
impact of our intervention. In contrast to more trad-
itional research studies, the project will not employ ex-
pert, highly trained staff in leading academic medical
centers to deliver the intervention; rather the interven-
tion will be implemented within real-world settings with
tailoring of strategies to meet the needs of each site.
Similarly, a decision was made to be as inclusive as pos-
sible in the patient intake rather than using strict eligi-
bility criteria selecting for non-complicated, highly
motivated patients who often fare better in health pro-
motion programs. Finally, practice participation is not
limited to practices with excellent state of the art EHRs
serving technology savvy patients; thus, a difficult bal-
ance has been sought between maximizing the use of
technology whenever possible and developing protocols
applicable to a range of settings. All of these decisions
could reduce the initial effect size, or produce different
results across different contexts, subgroups or settings.
However, despite this possibility, we suggest that the
project remains a worthwhile investment that will pro-
vide invaluable information about ‘what works under
what conditions for what groups for what outcomes’—
in a relatively short time frame [71].
The study design has many strengths, including the
highly pragmatic nature of the protocol, as evidenced by
the PRECIS ratings. Given the stakeholder involvement
throughout, the results should be highly relevant and
sensitive to both the primary care context as well as to
the growing emphasis on patient-centered care for im-
proving population health and well being. Anticipating
the relevance of the results to diverse primary care prac-
titioners as well as different healthcare settings and net-
works, the rapid and iterative processes using mixed
methods should provide in-depth feedback to more
quickly inform practice and policy. Inclusion of data on
reach, implementation under different conditions, as
well as implementation and replication cost estimates
should provide the types of transparent information
needed by potential adopting settings. The tools and ma-
terials used in the MOHR project, including the stan-
dardized brief assessment items, the MOHR automated
assessment and feedback tool, and the assessment proce-
dures are all in the public domain and available for
others to use or adapt (www.MyOwnHealthReport.org).Replications and extensions are encouraged, and espe-
cially studies having the scope and funding to evaluate
issues such as longer-term sustainability, health behavior
changes, and health outcomes.
The MOHR study serves as an example of a prag-
matic, participatory design that leverages resources and
tailors design elements to a range of local settings, while
maintaining the essential elements and scientific rigor of
a randomized comparison trial. This design is necessary,
given that the MOHR study aims to assess whether it is
feasible for a broad range of primary care practices to
systematically patient reported health behavior and psy-
chosocial assessments. Outcomes will include all neces-
sary implementation elements including feasibility,
impact on care, the influence of setting and context, and
the expense of implementation. These findings should
be of interest to researchers, practitioners, and policy
makers attempting to make healthcare more patient-
centered and relevant.Competing interests
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